Stay updated on Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new Revision: v3.4.2 entry to the history and removed older notices (including the lapse in government funding) and a prior Revision: v3.4.1 entry.
    Difference
    0.5%
    Check dated 2026-02-11T01:34:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide funding notice was added. The record history shows a new revision (v3.4.1) replacing the previous (v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T23:29:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI updates add a glossary option and color-coded change highlights for additions and deletions. The revision label has been updated to v3.4.0 and the No FEAR Act text has been adjusted.
    Difference
    0.6%
    Check dated 2026-01-27T23:50:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new 'Study Status' section was added to the history with a 2026-01-09 entry (Revision: v3.3.4). The prior 2025-05-28 entry for Revision: v3.3.3 was removed.
    Difference
    0.3%
    Check dated 2026-01-14T01:32:36.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.
    Difference
    0.1%
    Check dated 2025-12-23T07:58:06.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.2 instead of Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T15:11:19.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.